Dentsply Sirona Inc. XRAY
We take great care to ensure that the data presented and summarized in this overview for DENTSPLY SIRONA Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding XRAY
View all-
Vanguard Group Inc Valley Forge, PA21.1MShares$276 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.7MShares$244 Million0.01% of portfolio
-
First Eagle Investment Management, LLC14.2MShares$185 Million0.46% of portfolio
-
Aqr Capital Management LLC Greenwich, CT13.3MShares$174 Million0.18% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA12.4MShares$162 Million0.73% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$143 Million0.02% of portfolio
-
Lazard Asset Management LLC New York, NY10.1MShares$132 Million0.25% of portfolio
-
Cooke & Bieler LP9.15MShares$119 Million1.63% of portfolio
-
State Street Corp Boston, MA7.1MShares$92.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.85MShares$76.4 Million0.02% of portfolio
Latest Institutional Activity in XRAY
Top Purchases
Top Sells
About XRAY
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Insider Transactions at XRAY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 08
2025
|
Gregory T Lucier Director |
BUY
Bona fide gift
|
Indirect |
24,047
+50.0%
|
-
|
Aug 08
2025
|
Gregory T Lucier Director |
SELL
Bona fide gift
|
Direct |
24,047
-22.61%
|
-
|
Aug 08
2025
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,858
+3.5%
|
-
|
Aug 08
2025
|
Andrea L. Frohning SVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
788
-2.31%
|
$9,456
$12.96 P/Share
|
Jul 28
2025
|
Simon D Campion President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,566
-11.96%
|
$521,056
$16.07 P/Share
|
Jul 11
2025
|
Daniel T Scavilla President, CEO & Member of BOD |
BUY
Grant, award, or other acquisition
|
Direct |
210
+1.19%
|
-
|
Jul 11
2025
|
Janet S. Vergis Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.31%
|
-
|
Jul 11
2025
|
Richard C Rosenzweig EVP, Corp Dev, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
595
+0.7%
|
-
|
Jul 11
2025
|
Robert Anthony Johnson SVP, Chief Supply Chain Office |
BUY
Grant, award, or other acquisition
|
Direct |
755
+0.61%
|
-
|
Jul 11
2025
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
202
+0.2%
|
-
|
Jul 11
2025
|
Jonathan Jay Mazelsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
279
+0.98%
|
-
|
Jul 11
2025
|
Leslie F Varon Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.29%
|
-
|
Jul 11
2025
|
Matthew E Garth EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
432
+0.98%
|
-
|
Jul 11
2025
|
Brian T Gladden Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.77%
|
-
|
Jul 11
2025
|
Betsy D Holden Director |
BUY
Grant, award, or other acquisition
|
Direct |
502
+0.93%
|
-
|
Jul 11
2025
|
Kevin Czerney VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181
+0.67%
|
-
|
Jul 11
2025
|
Willie A Deese Director |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.24%
|
-
|
Jul 11
2025
|
Andrea L. Frohning SVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
304
+0.89%
|
-
|
Jul 11
2025
|
Michael J Barber Director |
BUY
Grant, award, or other acquisition
|
Direct |
210
+1.19%
|
-
|
Jul 11
2025
|
Simon D Campion President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,260
+0.46%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 321K shares |
---|---|
Bona fide gift | 24K shares |
Open market or private purchase | 32.4K shares |
Payment of exercise price or tax liability | 96.4K shares |
---|---|
Bona fide gift | 24K shares |